Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses

European Journal of Immunology

Volumn 42, Issue 9, 2012, Pages 2343-2353

  Ueno, Takuya ^a,b   Yeung, Melissa Y ^a   Mcgrath, Martina ^a   Yang, Sunmi ^a   Zaman, Nadia ^a   Snawder, Benjamin ^a   Padera, Robert F ^a   Magee, Ciara N ^a   Gorbatov, Rostic ^b   Hashiguchi, Masaaki ^c   Azuma, Miyuki ^c   Freeman, Gordon J ^d   Sayegh, Mohamed H ^a   Najafian, Nader ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Costimulatory molecules; T helper cells; Transplantation

Indexed keywords

ABATACEPT; B7 H3 PROTEIN; BLOCKING ANTIBODY; CD28 ANTIGEN; GAMMA INTERFERON; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD28; B7 ANTIGENS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOCONJUGATES; INTERFERON-GAMMA; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84865750116     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242501     Document Type: Article

References (30)

1. Li, X. C., Rothstein, D. M. and Sayegh, M. H., Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 2009. 229: 271-293.
2. Yi, K. H. and Chen, L., Fine tuning the immune response through B7-H3 and B7-H4. Immunol. Rev. 2009. 229: 145-151.
3. Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H. et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2001. 2: 269-274.
4. Luo, L., Chapoval, A. I., Flies, D. B., Zhu, G., Hirano, F., Wang, S., Lau, J. S. et al. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells. J. Immunol. 2004. 173: 5445-5450.
5. Hashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H. and Azuma, M., Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc. Natl. Acad. Sci. USA 2008. 105: 10495-10500.
6. Wang, L., Fraser, C. C., Kikly, K., Wells, A. D., Han, R., Coyle, A. J., Chen, L. and Hancock, W. W., B7-H3 promotes acute and chronic allograft rejection. Eur. J. Immunol. 2005. 35: 428-438.
7. Suh, W. K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S. et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 2003. 4: 899-906.
8. Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y. and Dong, C., Murine B7-H3 is a negative regulator of T cells. J. Immunol. 2004. 173: 2500-2506.
9. Leitner, J., Klauser, C., Pickl, W. F., Stokl, J., Majdic, O., Bardet, A. F., Kreil, D. P. et al. B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction. Eur. J. Immunol. 2009. 39: 1754-1764.
10. Sun, X., Vale, M., Leung, E., Kanwar, J. R., Gupta, R. and Krissansen, G. W., Mouse B7-H3 induces antitumor immunity. Gene Ther. 2003. 10: 1728-1734.
11. Lupu, C. M., Eisenbach, C., Lupu, A. D., Kuefner, M. A., Hoyler, B., Stremmel, W. and Encke, J., Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer. Oncol. Rep. 2007. 18: 745-748.
12. Sun, Y., Wang, Y., Zhao, J., Gu, M., Giscombe, R., Lefvert, A. K. and Wang, X., B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006. 53: 143-151.
13. Zang, X., Sullivan, P. S., Soslow, R. A., Waitz, R., Reuter, V. E., Wilton, A., Thaler, H. T. et al. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod. Pathol. 2010. 23: 1104-1112.
14. Zang, X., Thompson, R. H., Al-Ahmadie, H. A., Serio, A. M., Reuter, V. E., Eastham, J. A., Scardino, P. T. et al. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc. Natl. Acad. Sci. USA 2007. 104: 19458-19463.
15. Vincenti, F. and Luggen, M., T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu. Rev. Med. 2007. 58: 347-358.
16. Nickerson, P., Steurer, W., Steiger, J. R., Zheng, X., Steele, A. W. and Strom, T. B., Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 1994. 6: 757-764.
17. Ling, V., Wu, P. W., Spaulding, V., Kieleczawa, J., Luxenberg, D., Carreno, B. M. and Collins, M., Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics 2003. 82: 365-377.
18. Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B. and Zhang, X., Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology 2008. 123: 538-546.
19. Castriconi, R., Dondero, A., Augugliaro, R., Cantoni, C., Carnemolla, B., Sementa, A. R., Negri, F. et al. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc. Natl. Acad. Sci. USA 2004. 101: 12640-12645.
20. Suh, W. K., Wangt, S. X., Jheon, A. H., Moreno, L., Yoshinaga, S. K., Ganss, B., Sodek, J. et al. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc. Natl. Acad. Sci. USA 2004. 101: 12969-12973.
21. Francisco, L. M., Sage, P. T. and Sharpe, A. H., The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 2010. 236: 219-242.
22. Sandner, S. E., Clarkson, M. R., Salama, A. D., Sanchez-Fueyo, A., Domenig, C., Habicht, A., Najafian, N. et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 2005. 174: 3408-3415.
23. Yang, J., Riella, L. V., Robles, S., Zhao, X., Yuan, X., Vanguri, V., Paterson, A. M. et al. Blockade of the PDL1:B7.1 pathway enhances the alloimmune response in vivo. Am. J. Transplant. 2010. 10: 361.
24. Ozkaynak, E., Wang, L., Goodearl, A., McDonald, K., Qin, S., O'Keefe, T., Duong, T. et al. Programmed death-1 targeting can promote allograft survival. J. Immunol. 2002. 169: 6546-6553.
25. Gao, W., Demirci, G., Strom, T. B. and Li, X. C., Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 2003. 76: 994-999.
26. Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T. et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 2003. 198: 63-69.
27. Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J. C., Anders, R. A., Sun, Y. et al. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 2004. 113: 694-700.
28. Yantha, J., Tsui, H., Winer, S., Song, A., Wu, P., Paltser, G., Ellis, J. and Dosch, H. M., Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia. Diabetes 2010. 59: 2588-2596.
29. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261-268.
30. Sun, M., Richards, S., Prasad, D. V. R., Mai, X. M., Rudensky, A. and Dong, C., Characterization of mouse and human B7-H3 genes. J. Immunol. 2002. 168: 6294-6297.